Brightening the Future of Immunology with New Frontiers in Science

By exploring new frontiers in science and technology, we strive to accelerate innovation of transformational medicines that deliver more years of life and quality of life for patients and families living with immune-mediated conditions.

Unlocking hope

Address significant unmet medicals needs in immunology

With over 20 years of research under our belt, we have built a vast proprietary knowledge of disease biology.

By exploring new frontiers in science and technology, we strive to accelerate innovation of transformational medicines that deliver more years of life and quality of life for patients and families living with immune-mediated conditions.

Pioneering for patients

High unmet need for immune-mediated diseases

4 million people

worldwide are affected by immune-mediated diseases1

80 types

of immune-mediated diseases

Immune system

mistakenly attacks healthy cells and tissues

1 World Health Organization. (2020). Global Report on Immune-Mediated Diseases. https://www.who.int/publications/i/item/global-report-on-immune-mediated-diseases)

Building our immunology portfolio

Our focus in immunology

Striving to deliver targeted treatments for immune-mediated diseases

All about Galapagos

Our corporate presentation

Everything you need to know about Galapagos in one slide deck.

Multiple drug modalities

Rapidly advancing and expanding our immunology pipeline

We are more passionate than ever about rapidly advancing and expanding our immunology pipeline, and want to brighten the horizon of possibilities with multiple modes-of-action and drug modalities.

We are evaluating CAR-T therapy for the treatment of refractory systemic lupus erythematosus and other chronic immune-mediated diseases to expand our cell therapy portfolio.

Disease areas

More about our work in Oncology

We are united around our mission to redefine the future of cancer treatment. Our goal is to help people facing cancer live longer, better lives.

Partnerships

Work with us!

We are adding new capabilities, technologies and product candidates through internal and external innovation. Let’s start #PioneeringForPatients, together!